Day One Biopharmaceuticals Inc (DAWN) — Cash Flow Reinvestment Rate
Latest as of September 2024:
2.43x
Day One Biopharmaceuticals Inc (DAWN) has a Cash Flow Reinvestment Rate of 2.43x as of September 2024, reinvesting $123.42 Million (capex $55.72 Million plus investments $-67.70 Million) from operating cash flow of $50.75 Million. Check Day One Biopharmaceuticals Inc (DAWN) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
2.43x
(Capex + Investments) / Operating CF
Total Reinvested
$123.42 Million
Capex + Investments
Operating Cash Flow
$50.75 Million
USD
Capital Expenditures
$55.72 Million
USD
Annual Cash Flow Reinvestment Rate for Day One Biopharmaceuticals Inc (None–None)
Year-by-year capital reinvestment analysis for Day One Biopharmaceuticals Inc. For live market cap and broader valuation context, see DAWN market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow